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Abstract 174 
In this study, a hierarchical nano/microfibrous chitosan/collagen scaffold that approximates 175 
structural and functional attributes of native extracellular matrix (ECM), has been developed for 176 
applicability in skin tissue engineering. Scaffolds were produced by electrospinning of chitosan 177 
followed by imbibing of collagen solution, freeze-drying  and subsequent cross-linking of two 178 
polymers. Scanning electron microscopy showed formation of layered scaffolds with 179 
nano/microfibrous architechture. Physico-chemical properties of scaffolds including tensile 180 
strength, swelling behavior and biodegradability were found satisfactory for intended 181 
application. 3T3 fibroblasts and HaCaT keratinocytes showed good in vitro cellular response on 182 
scaffolds thereby indicating the matrices′ cytocompatible nature. Scaffolds tested in an ex vivo 183 
human skin equivalent (HSE) wound  model, as a preliminary alternative to animal testing, 184 
showed keratinocyte migration and wound re-epithelization — a pre-requisite for healing and 185 
regeneration. Taken together, the herein proposed chitosan/collagen scaffold, shows good 186 
potential for skin tissue engineering. 187 
Keywords: Nano/micro architecture, Chitosan, Collagen, Skin Tissue Engineering 188 
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1. Introduction 194 
Native extracellular matrix (ECM) is a dynamic fibrillar network of self-assembled proteins 195 
and polysaccharides rather than a mere structural support for cells.
1,2
 Acting as a reservoir for 196 
soluble cell signaling molecules, the ECM contributes enormously to tissue morphogenesis, 197 
homeostasis and regeneration.
3
 The quest to understand both structural and functional attributes 198 
of ECM has motivated researchers to design materials with objective of mimicking matrices’ 199 
architecture, physico-chemical properties, and biomolecular composition. The ultimate desired 200 
for these bioinspired templates is to induce cellular responses as natural ECM, with special 201 
emphasis on matrix’s cell adhesion potential, biodegradability, and proteolytic susceptibility. 202 
Multi-scale fibrillar networks have been developed in recent times so as to mimic the ECM 203 
architecture and elucidate better cellular behavior. 
4-7
 Tuzlakoglu et al. explored the potential of 204 
nano/microfiber combined scaffolds, produced by electrospinning collagen onto starch-based 205 
fiber meshes for bone regeneration.
8
 Results clearly indicated the significant role of collagen 206 
nanofibers in influencing viability and cytoskeletal organization of rat bone marrow stromal 207 
cells and human osteoblast-like cells. Similarly, by employing electrospun poly (ε-208 
caprolactone) mats, with alternating micro and nanofibrous layers, Pham et al. showed 209 
enhanced spreading of rat marrow stromal cells on scaffolds.
9 
210 
From the perspective of skin tissue engineering, a multi-scale fibrillar scaffold can be 211 
advantageous. Native human skin has a layered architecture with an overlying epidermis that 212 
contains keratinocytes, melanocytes, Merckl cells, and an underlying dermis that contains 213 
mainly fibroblasts within a fibrous connective tissue matrix. The two layers are mutually 214 
separated by an intermediate acellular glycoproteinacous basement membrane layer.
10  
This 215 
layer is composed of protein microfilaments, containing collagen III/ IV/ VII, integrin, laminin 216 
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332, fibronectin and proteoglycans, along with other complex nanometer sized fibrous 217 
topographies that synchronously influence bio-chemical functionalities of native tissue. The 218 
underlying dermal layer comprises mostly of nano/microfibrous collagens, polysaccharides and 219 
water.
11
 For the development of an engineered skin graft, it is essential to emulate the 220 
nano/micro-scalar fibrous architecture of tissue matrix and its biological cell recognition 221 
character. Combination of fabrication techniques like extrusion based rapid-prototyping, 222 
microfabrication, and spinning can be employed for reproducing architecture of ECM in 223 
scaffolds.
12-15
 For reconstitution of  the bio-adhesive character of ECMs, cell-recognizing 224 
domains can be introduced into scaffolds either by direct grafting of integrin binding units such 225 
as Arg-Gly-Asp (RGD), Asp-Gly-Glu-Ala (DGEA), or Tyr-Ile-Gly-Ser-Arg  (YIGSR) onto 226 
surface-active polymers or by introducing adhesive motif rich proteins, usually collagen, 227 
fibronectin, or vitronectin.
16-18 
228 
However, for successful skin regeneration, mimicking the architecture and biological cell 229 
recognition properties of ECM may not be adequate. Scaffolds should also provide critical 230 
functional roles like wound healing of native tissue matrix. Amongst the various stages 231 
involved in wound healing, closure of wound by migrating epithelial cells is crucial for 232 
restoration of intact epidermal barrier and protection of underlying tissue.
19
 In some 233 
pathological conditions, like diabetic ulcers and third degree burns, re-epithelization is greatly 234 
hampered which may lead to development of non-healing chronic wounds. A significant 235 
apprehensive feature of chronic wounds is the presence of over-activated inflammatory cells 236 
that stimulate fibroblasts to secrete high level of matrix metalloproteinase (MMP).
11
 This 237 
elevated MMP level not only denatures the non-viable collagen in wound beds, but also breaks 238 
down the viable collagen laid down by fibroblasts for granulation tissue formation.
11 
239 
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Additionally, fibroblasts at this stage fail to produce adequate levels of MMP inhibitors to 240 
restrict excess MMP activity.
20
 Various cells (e.g. fibroblasts, endothelial cells) exist in 241 
senescent form and can hardly communicate with each other or function properly. All these 242 
events taken together restrict the formation of a suitable matrix needed for efficient cell 243 
migration and wound closure.
21 
244 
A collagen based matrix can be promising in this regard for tackling issues of excess 245 
MMP activity by acting as a ‘sacrificial substrate’ in the wound.
22 
Moreover, breakdown 246 
products of collagen are chemotactic for cells essential for granulation tissue formation.
23
 Type 247 
I collagen being the major structural and functional protein of dermal matrix, migrating 248 
keratinocytes tend to interact with this protein and enhance collagenase production .
24 
The 249 
collagenase thus produced in turn facilitates disassociation of keratinocytes from collagen rich 250 
substrates thereby allowing efficient keratinocyte migration over the provisional dermal matrix 251 
and effective wound closure .
21
 However, in spite of its significant role in wound re-252 
epithelization and healing, using just type I collagen for tissue engineering applications is 253 
restricted due to its fast biodegradation, poor mechanical properties and issues related to in vivo 254 
contraction.
25 
In natural ECM, proteoglycans and glycosaminoglycans are usually coupled with 255 
collagen to provide mechanical stability and compressive strength.
26 
Hereof, incorporation of 256 
chitosan, a glycosaminoglycan-like biodegradable polymer, into collagen based scaffolds may 257 
help in overcoming the potential limitations of collagen matrices. Chitosan, along with 258 
providing mechanical stability to collagen scaffolds, considerably contributes to the in vitro 259 
cellular response of chitosan/collagen scaffolds owing to its cytocompatible nature.
27 
Moreover, 260 
the advantages that chitosan imparts to different aspects of wound healing, such as hemostasis, 261 
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antibacterial action and potential to accelerate collagen synthesis by fibroblasts, make it an 262 
attractive candidate for skin tissue engineering. 
25, 28
 263 
Various researchers have explored the potential of chitosan/collagen scaffolds for skin 264 
tissue engineering applications.
25, 29-30  
However, not many studies have been directed towards 265 
the development of a scaffold with the wholesome approach of mimicking structural, 266 
biochemical and functional attributes of native tissue. Thus to address this highly demanding 267 
area of research, the present study aims to develop a layered nano/microfibrous chitosan/collagen 268 
scaffold thereby approximating structural hierarchy, organization, biochemical composition and 269 
functional features of native skin ECM. Sequential electrospinning and freeze-drying techniques 270 
have been employed for development of layered scaffolds with hierarchical fiber diameters and 271 
pore sizes. Freeze-dried nano/microfibrous layer with micron scale inter-fiber spacings may 272 
allow easy cellular migration and proliferation, thereby contributing to development of a 273 
functional dermal substitute. Nano-scalar pore size of electrospun layer, on the other hand, may 274 
control evaporative water loss, promote mass transport, and restrict invasion by exogenous 275 
microorganisms.
19
In order to evaluate in vitro cytocompatibility and appropriateness of scaffolds 276 
for skin tissue engineering, cellular responses of 3T3 fibroblasts and HaCaT keratinocytes were 277 
separately studied on freeze dried collagen layer and electrospun chitosan layer, respectively. In 278 
addition, the scaffolds were tested in ex vivo human skin equivalent (HSE) model, as a 279 
preliminary alternative to in vivo animal testing, so as to assess their re-epithelization and wound 280 
healing potential. 281 
  282 
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2. Materials and Methods 283 
2.1 Fabrication of chitosan/collagen scaffolds 284 
2.1.1 Electrospinning of chitosan-PEO solution  285 
For this study, 3 wt % chitosan (average Mw ~ 710,000, <90% de-acetylated; Marine 286 
Chemicals, Kerala, India) and 10 wt % poly (ethylene oxide) (PEO, average Mw ~ 100,000; 287 
Sigma Aldrich, US) stock solutions, in 15M acetic acid, were used to prepare a 4:1 chitosan-PEO 288 
(w/w) blend (4C1P) for electrospinning. A 26 gauge blunt end stainless steel capillary needle 289 
was attached to a syringe containing 2 ml of 4C1P blend. Syringe was placed on a syringe pump 290 
(KD Scientific, Switzerland) that allowed precise control of solution flow rates in micro-liter 291 
range. Needle was connected to positive electrode of a high voltage DC power supply (30 kV, 292 
Glass Mann, Japan). A grounded cylindrical collector (6 cm diameter), wrapped in aluminum foil 293 
and rotating at 200 rpm, was placed at a tip-to-collector distance of 15 cm. Flow-rate of 8 294 
µL/min, 20 kV DC voltage were maintained throughout electrospinning process carried out at 295 
room temperature. Electrospun 4C1P mat was immersed in 5 wt % aqueous sodium-296 
tripolyphosphate (STPP, Loba Chem Mumbai, India) bath (pH 7) for 5 mins for ionotropic 297 
crosslinking of chitosan with tri-polyphosphates. This also facilitated easy retrieval of samples 298 
from foil surface. PEO and unreacted TPP were removed by incubation in aqueous medium at 299 
37°C for 5 days under shaking condition.
31 
Cross-linked samples (referred as Chi-CL) were air 300 
dried on a Teflon coated plate overnight.  301 
2.1.2 Freeze-drying of type I collagen on electrospun mats  302 
Collagen type I, used in this study, was extracted from scales of Labeo rohita using a two 303 
step demineralization and salting out process as reported by Pati et al.
32,33  
1 mg/ml of type I 304 
collagen solution was obtained by dissolving freeze-dried collagen in 0.5 M acetic acid and 305 
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overnight stirring at 4 °C. To obtain collagen fibers, the solution was further dialyzed against 306 
0.1M acetic acid and distilled water for 24 hours to attain pH ~ 6. Collagen solution was poured 307 
over Chi-CL mats, placed in rectangular molds, and frozen at -80 °C for 24 hrs followed by 308 
overnight lyophilization at -45 °C. The mats obtained (Chi-CL-Col) were treated with aqueous 309 
N-hydroxysuccinimide (NHS)/1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) (SRL 310 
Pvt. Ltd, Mumbai, India) solution (pH 5.5) to crosslink collagen.
34
 The NHS-EDC treated 311 
lyophilized samples thus obtained are referred as Chi-CL-Col-CL. Two different sides of Chi-312 
CL-Col-CL scaffolds containing the electrospun layer and collagen rich layer are labeled as Chi-313 
CL-Col-CL/U and Chi-CL-Col-CL/D, respectively. 314 
2.2 Physico-chemical characterisation of scaffolds 315 
2.2.1 Scanning electron microscopy 316 
Morphologies of Chi-CL, Chi-CL-Col and Chi-CL-Col-CL scaffolds were analyzed using 317 
scanning electron microscope (SEM, EVO 60/Zeiss, Germany) at an accelerating voltage of 10-318 
20 kV. The fully dried scaffolds were gold-coated (Polaron sputter coater) at 40 mA for 90 s 319 
prior to observation under SEM. Average fiber diameters were determined from SEM 320 
micrographs of  20 randomly chosen fibers using IT3 software  (University of Texas Health 321 
Centre, San Antonio, US).  322 
2.2.2 Porosity determination 323 
To determine porosity of scaffolds, fully dried Chi-CL and Chi-CL-Col-CL samples were 324 
cut into rectangular pieces. The mass (W1) and volume (V1) of each sample were recorded prior 325 
to immersion in pycnometer filled with absolute alcohol. After 2 hours of immersion masses of 326 
saturated samples (W2) were recorded. Porosities of scaffolds were determined from equation 327 
(1). 328 
                                    329 
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% Porosity = (W2 − W1) / (ρV1) ×100 (1) 330 
where ρ is the density of ethanol at 25 °C (= 789 kg/m³) 331 
2.2.3 ATR/FTIR spectroscopy 332 
ATR/FTIR spectra of the scaffolds and collagen powder were recorded using a Thermo 333 
Nicolet spectrophotometer (Model – NEXUS-870, Thermo Nicolet Corporation, Madison, WI, 334 
USA) with ZnSe crystal ATR accessory. For Chi-CL-Col-CL samples, ATR spectra of both 335 
sides (i.e. Chi-CL-Col-CL/U and Chi-CL-Col-CL/D) were recorded. For freeze-dried collagen 336 
powder, pellets were prepared along with KBr and FTIR spectra was recorded in transmission 337 
mode. All spectra were recorded from 500-4000 cm
-1
. 338 
2.2.4 Swelling behavior 339 
Chi-CL, Chi-CL-Col and Chi-CL-Col-CL scaffolds of known dry masses (Wd) were 340 
incubated in PBS at 37 °C for 24 hours. Swollen weights (Ww) of scaffolds were recorded at 341 
different time intervals until equilibrium. Swelling ratio of scaffolds was obtained from equation 342 
(2). 343 
% Swelling = [(Ww-Wd)/Wd] × 100  (2) 344 
2.2.5 Biodegradation kinetics 345 
In vitro biodegradation behaviour of collagen (Col), Chi-CL-Col and Chi-CL-Col-CL 346 
scaffolds of  were studied by collagenase digestion, as reported by Ma et al.
25
 In brief, the 347 
samples were incubated in PBS supplemented with  100 mg/ml (28 units) collagenase type I 348 
(Himedia, Mumbai, India) at 37°C for 4, 12, 24 and 72 h. At specific time intervals, the 349 
degradation was discontinued by incubating the sample mixture in ice bath followed by 350 
centrifugation at 1500 rpm for 10 min. The supernatant obtained was hydrolyzed with 6mM HCl 351 
at 120 °C for 12 h. The hydroxyproline content was assessed using UV spectroscopy. The 352 
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biodegradation degree of scaffolds is defined as percentage of hydroxyproline released at 353 
specific times to the fully degraded sample having same composition and weight. 354 
2.2.6 Mechanical properties 355 
Tensile properties of Chi-CL, Chi-CL-Col and Chi-CL-Col-CL scaffolds (n=5 for each) 356 
were evaluated through mechanical testing (Model H25KS, Hounsfield, UK) under tensile mode 357 
using a 25 N load-cell with cross-head speed of 0.5 mm/min. Scaffolds were sectioned into thin 358 
strips (~ 5 mm width, ~ 0.008 and 0.1 mm thickness for Chi-CL and Chi-CL-Col-CL, 359 
respectively) and clamped onto tensile grips. Initial gauge length of 10 mm was maintained for 360 
each test.  361 
2.3 In vitro cell culture using 3T3 fibroblasts and HaCaT keratinocytes 362 
3T3 fibroblast and HaCaT keratinocyte cells (obtained from NCCS, Pune) were 363 
maintained in humidified environment (37 °C, 5% CO2) and cultured in Dulbecco’s modified 364 
Eagle’s medium (DMEM; Himedia, Mumbai, India) with 10 % fetal bovine serum (FBS; 365 
Himedia, Mumbai, India) and 1% antibiotic agent (Himedia, Mumbai, India). For in vitro cell 366 
culture study, Chi-CL and Chi-CL-Col-CL scaffolds were cut into 8 mm diameter discs. Prior to 367 
cell seeding, scaffolds were sterilized using 70% ethanol  for 3 hrs, washed repeatedly with 368 
phosphate buffered saline (PBS) followed by overnight incubation in cell culture medium. 3T3 369 
fibroblasts were seeded onto the collagen rich layer of Chi-CL-Col-CL scaffold (i.e. Chi-CL-370 
Col-CL/U) at a density of 1 x 10
5
 cells / scaffold. A similar density of HaCaT keratinocytes were 371 
seeded on electrospun chitosan based layer (i.e. Chi-CL-Col-CL/D) of another set of Chi-CL-372 
Col-CL scaffolds. Cells were also seeded onto Chi-CL scaffolds and tissue culture polystyrene 373 
(TCP; positive control) for comparative analysis. The samples were incubated at 37 °C and 374 
culture medium was replaced every 24 hours. 375 
  376 
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2.3.1 Observation under SEM 377 
SEM microscopy was performed to evaluate morphological characteristics of 378 
proliferating 3T3 fibroblast and HaCaT keratinocytes seeded on scaffolds. After 1 and 7 days of 379 
culture, the cells were fixed in 2.5% glutaraldehyde for 30 min at 4°C followed by rinsing and 380 
dehydration in ascending series of aqueous ethanol (50–100%). To ensure complete drying, the 381 
samples were further vacuum dried and observed under SEM following conditions outlined in 382 
section 2.2.1. 383 
2.3.2 Cell viability assay 384 
Viability of 3T3 and HaCaT cells seeded on Chi-CL and Chi-CL-Col-CL scaffolds were 385 
assessed using live / dead viability/ cytotoxicity kit (Molecular Probes, Invitrogen, Eugene, OR, 386 
USA) following the manufacturer’s protocol. Briefly, cell-seeded scaffolds were washed 387 
thoroughly in PBS to remove traces of serum-supplemented DMEM medium. 1 mL of solution 388 
containing 2 µM calcein AM and 4 µM ethidium homodimer-1 was added to each sample and 389 
incubated for 30–45 min at room temperature. Samples were further washed thoroughly to avoid 390 
background staining and visualized under fluorescent microscope (Zeiss, Germany) with suitable 391 
filters. Live cell cytoplasm on staining emitted a green fluorescence while dead cell nuclei were 392 
stained red. 393 
Viable cell proliferation on Chi-CL, Chi-CL-Col-CL scaffolds and TCP were quantified 394 
using MTT assay using 3T3 and HaCaT cells, as reported by Datta et al.
35 
After 1, 3 and 7days 395 
of cell seeding, media was removed and samples were washed repeatedly with PBS followed by 396 
incubation in 5 mg/mL of MTT (3-(4, 5-Dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 397 
bromide, Sigma, US) solution at 37 ºC for 4 h. The insoluble formazan crystals were dissolved in 398 
DMSO by shaking for 30 mins. A standard curve was prepared using suspensions with known 399 
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number of cells, determined by an automated cell counter (Countess, Invitrogen). Absorbance 400 
was recorded at 570 nm using a Platescreen (RMS, Chandigarh, India). 401 
2.4 Application of scaffolds on ex vivo human skin equivalent (HSE) wound model 402 
To investigate the wound healing potential, Chi-CL and Chi-CL-Col-CL scaffolds were 403 
tested on an ex vivo human skin equivalent (HSE) model (n=3). HSEs were prepared from skin 404 
samples, collected from consenting patients undergoing elective abdominal and breast reduction 405 
surgeries, using a method reported by Xie et al.
36 
Ethics approval was obtained from Queensland 406 
University of Technology Review Board prior to skin collection. The study was carried out with 407 
strict adherence to Declaration of Helsinki Principles. Initially, keratinocytes were isolated from 408 
epidermal layer of skin and cultured in Full Green’s medium. For isolation of fibroblasts, the 409 
dermal pieces were immersed in DMEM medium (Invitrogen) with 0.05% collagenase A (type I; 410 
Invitrogen, Mulgrave, Australia) at 37 ° C, 5% CO2 for 18 h followed by centrifugation. The 411 
cells obtained were maintained in FBS supplemented DMEM medium. Decellulalrised de-412 
epidermised dermis (DED) was prepared using a technique, reported by Dawson et al.
37
 For 413 
preparation of DED-HSEs, sterile stainless steel rings having an inner diameter of 6.7 mm were 414 
placed onto the papillary side of each DED piece (1.8 cm × 1.8 cm) and 2× 10 
4
 number 415 
fibroblasts were seeded onto the matrix inside the ring. The samples were incubated for 72 hours 416 
prior to seeding of keratinocytes on top of fibroblasts. The samples were incubated for 48 hours 417 
followed by lifting to air-liquid interface. After 7 days of maintaining the samples at air-liquid 418 
interface, full thickness wounds (4 mm diameter) were created in HSEs by cutting through 419 
epidermal and dermal layers using a biopsy punch (Stiefel, North Carolina, USA), followed by 420 
removal of incised core. Chi-CL and Chi-CL-Col-CL scaffolds were also cut into 4 mm diameter 421 
discs using biopsy punch before stacking them into the incised wound in HSEs.  Wounded HSEs 422 
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were probed using histology after 14 d of application of scaffolds. Samples were thus fixed in 423 
4% neutral buffered formalin, followed by paraffin embedding, serial sectioning, hematoxylin 424 
and eosin staining and visualization under a Nikon Eclipse TE2000-U microscope equipped with 425 
Photometrics cool snap LS camera.  426 
2.5 Statistical analysis 427 
The results are presented here as mean ± standard deviation. Comparisons were made 428 
using Origin Pro8 software for paired t-tests and at 95% confidence intervals (p < 0.05) 429 
significant difference were asserted. 430 
3. Results and discussion  431 
3.1. Scaffold morphology 432 
Chitosan/collagen scaffolds with hierarchical nano/microfiber architecture were 433 
successfully developed by sequential electrospinning, freeze-drying and subsequent cross-434 
linking. Primarily, randomly aligned nanofiber mats with ~78 nm fiber diameter, ~ 81 % 435 
porosity, and nano-scale inter-fiber spacing were prepared by electrospinning chitosan/PEO 436 
blend. This was followed by cross-linking of nanofibers by TPP ions in order to stabilize their 437 
architecture in an aqueous/acidic medium (Fig 1a). Further, TPP cross-linked nanofiber (Chi-CL) 438 
mats were used as base materials on which type I collagen solution (~ pH 6) was freeze-dried to 439 
form layered scaffold architecture with multi-scale fiber diameters (0.3-15 µm) (Fig.1b). Fig. 1c 440 
and d represents two different layers of Chi-CL-Col scaffolds- the lower collagen based thick 441 
porous layer with submicron scale fiber diameters and upper chitosan based nanofibrous layer, 442 
respectively. Here it is to be noted that, the upper chitosan based nanofibrous layer was also 443 
partially covered with collagen fibers due to flowability of collagen solution prior to freeze 444 
drying. Actually, the collagen fibers, in the different layers of Chi-CL-Col scaffolds, were 445 
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formed during dialysis and subsequent freeze drying due to inherent amphiphilic property of the 446 
collagen molecules that facilitated fibrillogenesis by self-assembly at pH close to isoelectric 447 
point.
38
 Furthermore, these chitosan-collagen based scaffolds (Chi-CL-Col), having ~200 µm 448 
thickness, were crosslinked by NHS-EDC so as to tailor their degradation and improve 449 
mechanical integrity under in vitro conditions. Crosslinking of scaffolds caused insignificant 450 
microstructural changes and allowed retention of ~ 61% interconnected porosity, as in 451 
uncrosslinked ones.  452 
3.2. ATR/FTIR analysis 453 
ATR/FTIR spectra of collagen powder, Chi-CL, Chi-CL-Col, and either sides of Chi-CL-454 
Col-CL scaffolds (i.e. Chi-CL-Col-CL/U, and Chi-CL-Col-CL/D) are shown in Fig. 2a. The 455 
spectra of Chi-CL, Chi-CL-Col, Chi-CL-Col-CL/U, and Chi-CL-Col-CL/D showed 456 
characteristic chitosan peaks for amide I at ~ 1640 cm
-1 
(C=O stretching), amide II  at ~1534 cm
-1
 457 
(N-H in plane deformation), amide III at ~1380 cm
 -1 
and saccharide unit  at  898 cm
-1
. The 458 
spectra for collagen powder showed peaks at ~ 3318 cm
-1
 (amide A; N–H stretching), ~1640 cm
-
459 
1
 (amide I; C=O stretching), ~1534 cm
-1
 (amide II; N–H deformation). The peak intensities for 460 
Chi-CL-Col scaffold at ~ 1640 cm
-1 
(amide I) and ~1534 cm
-1 
(amide II) increased due to 461 
incorporation of collagen as expected. Further increase in peak intensities of amide I and amide 462 
II bands in Chi-CL-Col-CL/U and Chi-CL-Col-CL/D  spectra signifies successful NHS-EDC 463 
cross-linking though inter/intra molecular amide linkage in hybrid polymeric scaffold. While 464 
comparing the spectra of Chi-CL-Col-CL/D and Chi-CL-Col-CL/U, higher intensity amide I and 465 
II bands in the former indicated higher collagen content in the lower layer of Chi-CL-Col-CL 466 
scaffold.  467 
  468 
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3.3. Swelling and biodegradation of scaffolds 469 
A scaffold with appreciable swelling property is desirable for wound healing application 470 
as it can absorb moisture from exudating wound beds. Fig. 2b represents swelling behavior of 471 
Chi-CL, Chi-CL-Col and Chi-CL-Col-CL scaffolds in PBS (pH ~ 7.4) at 37
o
C. The Chi-CL 472 
scaffolds showed rapid swelling (~ 300 %) and attained equilibrium within first hour of 473 
incubation. On the other hand, Chi-CL-Col and Chi-CL-Col-CL took approximately 12 and 22 474 
hours, respectively to reach equilibrium. This may be attributed to greater water absorption 475 
capacity of porous collagen layer in Chi-CL-Col and Chi-CL-Col-CL scaffolds. The crosslinked 476 
chitosan-collagen scaffolds (Chi-CL-Col-CL) exhibited lesser swelling (~ 450 %) than the 477 
uncross-linked Chi-CL-Col scaffolds (~ 600 %) thereby manifesting their higher stability in 478 
aqueous medium.  479 
While considering a matrix for tissue engineering application, besides its swelling 480 
property, degradation kinetics is also vital. In this study, biodegradation degree of collagen (Col), 481 
Chi-CL-Col and Chi-CL-Col-CL was investigated in collagenase medium at 37°C (Fig. 2c). The 482 
uncross-linked type I collagen showed ~ 91% biodegradation in 4 hours and was completely 483 
degraded by 12 hours study period. The uncross-linked Chi-CL-Col scaffolds also underwent a 484 
rapid 44% degradation within 72 hour study period. The NHS/EDC cross-linked Chi-CL-Col-CL 485 
scaffolds showed relatively higher stability (~16% degradation in 72 h) which can be attributed 486 
to enhanced inter and intra-molecular interaction between parent polymers through carbodiimide 487 
mediated covalent cross-linking. 488 
3.4. Tensile properties 489 
Mechanical properties of an engineered scaffold play important roles in imparting 490 
stability during tissue integration and neo-tissue formation. The tensile properties of Chi-CL, 491 
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Chi-CL-Col and Chi-CL-Col-CL were determined and presented in Fig. 2d. Tensile strength of 492 
Chi-CL, Chi-CL-Col and Chi-CL-Col-CL were recorded as 5.9 ± 0.28 MPa, 6.96 ± 0.54 MPa 493 
and 7.59 ± 0.61 MPa, respectively. These high tensile strengths of scaffolds are associated with 494 
their fibrous architecture and large number of inter-fiber crossover points giving rise to intrinsic 495 
cohesive force. In case of Chi-CL-Col and Chi-CL-Col-CL scaffolds, the higher strengths in 496 
comparison to Chi-CL scaffolds are mainly due to incorporation of collagen fibrils and their 497 
intermolecular interactions with chitosan nanofibers as described in section 3.2. Elongation at 498 
break of Chi-CL, Chi-CL-Col and Chi-CL-Col-CL scaffolds were found to be 9.08 ± 0.67%, 499 
13.11 ± 0.58%, and 8.54 ± 2.1%, respectively. Incorporation of collagen microfibrils into 500 
chitosan based nanofiber network allowed significantly higher elongation (p < 0.05) of resultant 501 
samples (Chi-CL-Col) prior to failure mainly due to considerable inter-chain slippage under 502 
tension. However, marked reduction in elongation at break of NHS-EDC treated Chi-CL-Col 503 
scaffold (Chi-CL-Col-CL) was attributed to carbodiimide mediated cross-linking of chitosan and 504 
collagen that caused inter-fiber locking and restricted inter-chain slippage. Further, elastic 505 
modulus of Chi-CL, Chi-CL-Col, and Chi-CL-Col- CL scaffolds were recorded as 134.1±15.2 506 
MPa, 150.1±12.4 MPa, and 174.9±7.9 MPa, respectively. The results clearly indicated 507 
improvement in tensile properties of scaffolds due to collagen incorporation and subsequent 508 
NHS-EDC mediated crosslinking. 509 
3.5 Cell culture and cytocompatibility of scaffolds 510 
Attachment, viability, and proliferation of cells on scaffolds are crucial to assess matrix 511 
cytocompatibility and are prerequisites for any tissue engineering application. 512 
Adhesion/proliferation potentials of 3T3 fibroblasts and HaCaT keratinocytes on Chi-CL and 513 
Chi-CL-Col-CL scaffolds were evaluated by SEM at different time points after cell seeding. As 514 
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observed in SEM micrographs (Fig. 3), both scaffolds supported cell adhesion and growth of 3T3 515 
and HaCaT cells. After the first day of incubation, attachment of cells and their subsequent 516 
elongation was higher on Chi-CL-Col-CL scaffold (Fig. 3a, c). The cells also developed 517 
lamelipodial protrusions by day 1 on Chi-CL-Col-CL scaffold. For Chi-CL scaffolds, after 518 
similar incubation time, cells remained clustered and round shaped with non-spread morphology 519 
(Fig.3 b, d). This difference in initial cellular response between two scaffolds may be attributed 520 
to presence of collagen on Chi-CL-Col-CL scaffolds. RGD domains of collagen present high 521 
affinity chemotactic focal adhesion points to cells that cause integrin up-regulation, cascades 522 
intracellular signaling/transcription and promotes good initial cell attachment.
39
 The reason for 523 
better cellular elongation on Chi-CL-Col-CL scaffolds may be attributed to higher porosity and 524 
interconnectivity in collagen layer that facilitated easier cell distribution and movement. 525 
However after 7 d of incubation, both 3T3 and HaCaT cells underwent significant proliferation 526 
(as also observed from MTT assay) on both Chi-CL and Chi-CL-Col-CL scaffolds, along with 527 
development of extensive lamelipodial protrusions which may be indicative of good cell-material 528 
interactions (Fig. 3e, f, g, h).
40
 For Chi-CL scaffolds, nanofibers acted as positive stimuli after 529 
initial attachment phase and supported enhanced cell spreading and formation of a sheath like 530 
morphology by day 7. On the other hand, for Chi-CL-Col-CL scaffolds, nano/microfibers of 531 
collagen provided geometrical and biological signals for effective cell proliferation, distribution 532 
and migration due to their structural and biochemical resemblance with protein’s supramolecular 533 
arrangement in native environment. 534 
Viability of 3T3 fibroblasts and HaCaT keratinocyte cells on Chi-CL, Chi-CL-Col-CL 535 
scaffolds and TCP were assessed qualitatively and quantitatively after 1, 3 and 7 days, using 536 
live/dead assay and MTT assay respectively (Fig. 4). Results showed between two scaffolds, 537 
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Chi-CL-Col-CL exhibited superior cellular response, in terms of better initial attachment  by 538 
1day (121 ± 36  3T3 fibroblasts/ mm
2
;  62 ± 16 HaCaT keratinocytes/ mm
2
), rapid proliferation 539 
and viability after 3days ( 453 ± 20  3T3 fibroblasts/mm
2
;  194 ± 30 HaCaT keratinocytes/mm
2
), 540 
and 7days (760 ± 26  3T3 fibroblasts/mm
2
;  591 ± 42 HaCaT keratinocytes/ mm
2
). Conversely, 541 
cells grown on Chi-CL scaffolds showed comparatively less initial attachment after 1day of 542 
incubation (8 ± 5 3T3 fibroblasts/mm
2
; 20 ± 15 HaCaT keratinocytes/ mm
2
), and comparatively 543 
inferior cell viability after 3days (293 ± 45 3T3 fibroblasts/mm
2
; 132 ± 20 HaCaT 544 
keratinocytes/mm
2
) and 7days (460 ± 74 3T3 fibroblasts/mm
2
; 401 ± 43 HaCaT 545 
keratinocytes/mm
2
). The significant difference (p <0.05) in cellular viability on two scaffolds 546 
may be attributed to their disparity in initial cell adhesion properties due to presence of collagen. 547 
Good initial adherence has often been associated with superior cell viability in later stages, as 548 
also evident for Chi-CL-Col-CL scaffolds in this study.
41
 In comparison to the scaffolds, though 549 
TCP showed better cell adhesion after 1day of incubation (210 ± 56 3T3 fibroblasts/mm
2
; 168 ± 550 
40 HaCaT keratinocytes/mm
2
),  this difference was reduced after 3 days (505 ± 74 3T3 551 
fibroblasts/mm
2
; 398± 67 HaCaT keratinocytes/mm
2
) and 7 days (546 ± 130 3T3 552 
fibroblasts/mm
2
; 371 ± 40 HaCaT keratinocytes/mm
2
). The viable cell count on TCP was 553 
comparable on Chi-CL-Col-CL and Chi-CL after 3 and 7 days, respectively. In fact after 7days 554 
of incubation, viable cell count on Chi-CL-Col-CL was significantly higher than that of TCP (p 555 
<0.05), essentially due to the three-dimensional architecture of scaffolds providing relatively 556 
higher surface area. Cell proliferation rate on TCP, on the other hand, reduced after 3 days due to 557 
stagnancy in cellular growth caused by contact inhibition.  558 
  559 
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3.6 Wound healing potential of scaffolds  560 
An essential feature of wound healing and regeneration lies in restoration of intact 561 
epidermal barrier through re-epithelization. Controlled proliferation and directed migration of 562 
keratinocytes through dermal/provisional matrix is critical for re-epithelization and disparity in 563 
this function often relates to non-healing wounds.
19
 The present study evaluated potential of Chi-564 
CL and Chi-CL-Col-CL for re-epithelization and healing of full-thickness wounds in an ex vivo 565 
HSE model, as a preliminary alternative to animal testing (Fig. 5). Fig. 5 a, b and c represent the 566 
HSE model prior to any defect, after wound creation and application of scaffolds to wound, 567 
respectively. MTT staining of HSEs with Chi-CL, after 14 days of application, showed 568 
characteristic purple color development on surrounding HSE matrix but not on scaffolds 569 
signifying absence of viable cells in wound region (Fig. 5d). Histology results showed minimal 570 
number of Chi-CL discs were retained in HSE wounds after 14 days (Fig. 5e). However, the Chi-571 
CL discs that were retained in wound hardly supported any keratinocyte migration or re-572 
epithelization. On the other hand for HSE wounds with Chi-CL-Col-CL, MTT staining showed 573 
typical purple color development on scaffolds and adjacent HSE after 14 days, thereby indicating 574 
presence of viable cells (Fig. 5f). Histology results clearly indicated keratinocyte migration 575 
through Chi-CL-Col-CL and re-epithelization of HSE wounds after 14 days of scaffold 576 
application (Fig. 5g). The inset of Fig. 5 g shows development of stratified epidermis over HSE 577 
wounds with Chi-CL-Col-CL scaffolds. This enhanced re-epithelization potential of Chi-CL-578 
Col-CL may be attributed to presence of type I collagen in scaffold. Type I collagen provides 579 
binding and cleavage sites for collagenase I (MMP I), a matrix metalloproteinase whose optimal 580 
catalytic activity is vital for wound healing.
42
 Following an injury, MMP I facilitates removal of 581 
degraded ECM components in a wound and re-organizes the provisional matrix for efficient 582 
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keratinocyte migration.
24
 MMP I expression is consistently induced by primary keratinocytes, 583 
migrating across the wound bed, only when cells are in contact with type I collagen and not with 584 
basement membrane proteins or with other components of wound bed.
24
 Moreover, cleavage of 585 
type I collagen provides keratinocytes with a mechanism to maintain their directionality during 586 
re-epithelization. The above mentioned finding from previous reports, taken together, explains 587 
the defect closure phenomenon in HSEs with Chi-CL-Col-CL scaffolds. Chi-CL scaffolds being 588 
devoid of collagen could not necessarily direct the MMP I production and keratinocyte 589 
migration. MMP I, that are produced by keratinocytes in wound boundary, did not get suitable 590 
binding and cleavage sites in Chi-CL scaffolds and hence could not maintain cellular migration 591 
necessary for re-epithelization..  592 
As also observed from histology results, both Chi-CL and Chi-CL-Col-CL scaffolds 593 
facilitated minimal/no fibroblast migration and related ECM synthesis which restricted complete 594 
healing of full-thickness wounds. The probable reason for such a phenomenon may be absence 595 
of macrophages in HSE model, that secrete pro-inflammatory cytokines (eg .TNF- α, IL-1bβ) 596 
responsible for fibroblast mediated collagen synthesis and deposition in wound.
21
 It is anticipated 597 
that, application of scaffolds in an animal model may provide a better insight to their full-598 
thickness wound healing potential, due to presence of suitable cells, cytokines and growth factors 599 
present in vivo. Results also indicated that stacks of scaffold discs could not be fitted optimally in 600 
wound thereby decreasing their stability during healing and further histological processing (Fig. 601 
5g). Air spaces occluded the scaffold stacks and hence it became difficult to set up a three 602 
dimensional bridge with interconnected porosity so as to facilitate fibroblast migration into 603 
wound (inset of Fig. 5g). In order to overcome stability and stacking related limitations, current 604 
research is being directed in our laboratory towards development of three-dimensional plug like 605 
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scaffolds, closely mimicking the thickness of native skin. Possibilities of using cytocompatible 606 
glues are also being explored in order to ensure that scaffolds remain in contact and adhered to 607 
wound edges and bed. Ex vivo and in vivo wound re-epithelization and healing studies are also 608 
being carried out using 3-D chitosan/collagen plug scaffolds, and will be reported. 609 
4. Conclusions 610 
The present work demonstrates successful development of chitosan-collagen scaffolds 611 
with hierarchical nano/microfiber architecture as a support matrix for wound healing and skin 612 
tissue engineering applications. Physico-chemical properties of prepared scaffolds were found 613 
suitable for intended purpose. 3T3 fibroblasts and HaCaT keratinocytes cultured on chitosan- 614 
collagen based scaffolds showed superior cellular response in comparison to the ones without 615 
collagen. Our results also demonstrate that topical application of these chitosan-collagen 616 
scaffolds in human skin equivalent models can promote keratinocyte migration and re-617 
epithelization in full thickness wounds. Such topical mode of action is promising for skin tissue 618 
engineering applications, as they hold potential to overcome the persistent problem of full 619 
thickness wound healing and regeneration.   620 
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List of figures 736 
Figure No Caption 
Fig. 1 SEM micrographs of  (a) electrospun 4:1 chitosan/PEO nanofibers treated with STPP (Chi-
CL), (d)cross-sectional view of layered chitosan-collagen scaffolds (Chi-CL-Col) ; (c) 
Lower collagen rich layer of  Chi-CL-Col scaffolds (d)  Upper electrospun chitosan/freeze-
dried collagen based layer of Chi-CL-Col scaffolds.  
Fig. 2 (a) ATR/FTIR spectra of  STPP treated chitosan based nanofibers (Chi-CL), collagen 
powder, chitosan-collagen scaffolds (Chi-CL-Col) and either sides of NHS-EDC treated 
chitosan-collagen (Chi-CL-Col-CL) scaffolds i.e. Chi-CL-Col-CL/U and Chi-CL-Col-
CL/D; (b) Swelling behavior of Chi-CL, Chi-CL-Col and Chi-CL-Col-CL ; (c) In vitro 
biodegradation behavior of collagen (Col), Chi-CL-Col and Chi-CL-Col-CL and (d) 
Tensile properties of Chi-CL, Chi-CL-Col and Chi-CL-Col-CL. 
Fig. 3 SEM micrographs showing attachment and proliferation of 3T3 fibroblasts and HaCaT 
keratinocytes on STPP treated chitosan based nanofiber (Chi-CL) and NHS-EDC treated 
chitosan-collagen scaffolds (Chi-CL-Col-CL) scaffolds after 1 and 7 days. Upper and 
lower layers of Chi-CL-Col-CL scaffolds have been labeled as Chi-CL-Col-CL/U and Chi-
CL-Col-CL/D. ( a,b) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL , respectively 
after 1 d; (c,d) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, respectively after 
1 d; (e,f) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL, respectively after 7d; (g,h) 
HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, respectively after 7d. 
Fig. 4 Fluorescent microscopic images of Calcein AM/ Ethidium homodimer stained  3T3 
fibroblasts and HaCaT keratinocytes on STPP treated chitosan based nanofiber (Chi-CL) 
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and NHS-EDC treated chitosan-collagen scaffolds (Chi-CL-Col-CL) scaffolds after 1, 3 
and 7 days. Upper and lower layers of Chi-CL-Col-CL scaffolds have been labeled as Chi-
CL-Col-CL/U and Chi-CL-Col-CL/D. (a,b) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  
Chi-CL , respectively after 1 d; (c,d) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-
CL, respectively after 1 d; (e,f) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL, 
respectively after 3 d; (g,h) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, 
respectively after 3d.; (i,j) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL, respectively 
after 7 d; (k,l) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, respectively after 
7d ; (m,n) viable cell count on Chi-CL-Col-CL, Chi-CL scaffolds and tissue culture 
polystyrene (TCP) after 1, 3 and 7 days using 3T3 fibroblasts and HaCaT keratinocytes, 
respectively. 
Fig. 5 Optical images of (a) Human skin equivalent model (HSE), (b) wound created on HSE, (c) 
Scaffolds placed on wounded HSE (d) MTT stained STPP treated chitosan based nanofiber 
scaffolds (Chi-CL)  after 14 d in wounded HSE (d) Light microscopic images of  H&E 
stained  HSE wound after 14 d of treatment with STPP treated chitosan based nanofibrous 
scaffold (Chi-CL) (at 4X magnification) , (e) Digital image of MTT stained NHS-EDC 
treated chitosan-collagen scaffolds (Chi-CL-Col-CL) after 14 d in wounded HSE, (f) Light 
microscopic image of  H&E stained NHS-EDC treated chitosan-collagen scaffolds (Chi-
CL-Col-CL) after 14 d in wounded HSE (at 4X magnification). The inset of (f) represents 
of 10 X magnified image of selected area (shown by dotted square). 
 737 
Page 35 of 40
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig 1. SEM micrographs of  (a) electrospun 4:1 chitosan/PEO nanofibers treated with STPP (Chi-CL), 
(d)cross-sectional view of layered chitosan-collagen scaffolds (Chi-CL-Col) ; (c) Lower collagen rich layer 
of  Chi-CL-Col scaffolds (d)  Upper electrospun chitosan/freeze-dried collagen based layer of Chi-CL-Col 
scaffolds.  
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Fig 2. (a) ATR/FTIR spectra of  STPP treated chitosan based nanofibers (Chi-CL), collagen powder, chitosan-
collagen scaffolds (Chi-CL-Col) and either sides of NHS-EDC treated chitosan-collagen (Chi-CL-Col-CL) 
scaffolds i.e. Chi-CL-Col-CL/U and Chi-CL-Col-CL/D; (b) Swelling behavior of Chi-CL, Chi-CL-Col and Chi-CL-
Col-CL ; (c) In vitro biodegradation behavior of collagen (Col), Chi-CL-Col and Chi-CL-Col-CL and (d) Tensile 
properties of Chi-CL, Chi-CL-Col and Chi-CL-Col-CL.  
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Page 37 of 40
John Wiley & Sons, Inc.
Journal of Biomedical Materials Research: Part A
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
  
 
 
Fig 3.SEM micrographs showing attachment and proliferation of 3T3 fibroblasts and HaCaT keratinocytes on 
STPP treated chitosan based nanofiber (Chi-CL) and NHS-EDC treated chitosan-collagen scaffolds (Chi-CL-
Col-CL) scaffolds after 1 and 7 days. Upper and lower layers of Chi-CL-Col-CL scaffolds have been labeled as 
Chi-CL-Col-CL/U and Chi-CL-Col-CL/D. ( a,b) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL , respectively 
after 1 d; (c,d) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, respectively after 1 d; (e,f) 3T3 
fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL, respectively after 7d; (g,h) HaCaT keratinocytes on Chi-CL-Col-
CL/U  and  Chi-CL, respectively after 7d.  
57x24mm (300 x 300 DPI)  
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Fig 4. Fluorescent microscopic images of Calcein AM/ Ethidium homodimer stained  3T3 fibroblasts and 
HaCaT keratinocytes on STPP treated chitosan based nanofiber (Chi-CL) and NHS-EDC treated chitosan-
collagen scaffolds (Chi-CL-Col-CL) scaffolds after 1, 3 and 7 days. Upper and lower layers of Chi-CL-Col-CL 
scaffolds have been labeled as Chi-CL-Col-CL/U and Chi-CL-Col-CL/D. (a,b) 3T3 fibroblasts on Chi-CL-Col-
CL/D  and  Chi-CL , respectively after 1 d; (c,d) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, 
respectively after 1 d; (e,f) 3T3 fibroblasts on Chi-CL-Col-CL/D  and  Chi-CL, respectively after 3 d; (g,h) 
HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, respectively after 3d.; (i,j) 3T3 fibroblasts on Chi-CL-
Col-CL/D  and  Chi-CL, respectively after 7 d; (k,l) HaCaT keratinocytes on Chi-CL-Col-CL/U  and  Chi-CL, 
respectively after 7d ; (m,n) viable cell count on Chi-CL-Col-CL, Chi-CL scaffolds and tissue culture 
polystyrene (TCP) after 1, 3 and 7 days using 3T3 fibroblasts and HaCaT keratinocytes, respectively.  
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Fig 5. Optical images of (a) Human skin equivalent model (HSE), (b) wound created on HSE, (c) Scaffolds 
placed on wounded HSE (d) MTT stained STPP treated chitosan based nanofiber scaffolds (Chi-CL)  after 14 
d in wounded HSE (d) Light microscopic images of  H&E stained  HSE wound after 14 d of treatment with 
STPP treated chitosan based nanofibrous scaffold (Chi-CL) (at 4X maginification) , (e) Digital image of MTT 
stained NHS-EDC treated chitosan-collagen scaffolds (Chi-CL-Col-CL) after 14 d in wounded HSE, (f) Light 
microscopic image of  H&E stained NHS-EDC treated chitosan-collagen scaffolds (Chi-CL-Col-CL) after 14 d 
in wounded HSE (at 4X maginification). The inset of (f) represents of 10 X magnified image of selected area 
(shown by dotted square).  
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